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Background. Many emergency department (ED) providers do not follow guideline recommendations for the
use of the pneumonia severity index (PSI) to determine the initial site of treatment for patients with community-
acquired pneumonia (CAP). We identified the reasons why ED providers hospitalize low-risk patients or manage
higher-risk patients as outpatients.
Methods. As a part of a trial to implement a PSI-based guideline for the initial site of treatment of patients
with CAP, we analyzed data for patients managed at 12 EDs allocated to a high-intensity guideline implementation
strategy study arm. The guideline recommended outpatient care for low-risk patients (nonhypoxemic patients
with a PSI risk classification of I, II, or III) and hospitalization for higher-risk patients (hypoxemic patients or
patients with a PSI risk classification of IV or V). We asked providers who made guideline-discordant decisions
on site of treatment to detail the reasons for nonadherence to guideline recommendations.
Results. There were 1,306 patients with CAP (689 low-risk patients and 617 higher-risk patients). Among
these patients, physicians admitted 258 (37.4%) of 689 low-risk patients and treated 20 (3.2%) of 617 higher-risk
patients as outpatients. The most commonly reported reasons for admitting low-risk patients were the presence
of a comorbid illness (178 [71.5%] of 249 patients); a laboratory value, vital sign, or symptom that precluded ED
discharge (73 patients [29.3%]); or a recommendation from a primary care or a consulting physician (48 patients
[19.3%]). Higher-risk patients were most often treated as outpatients because of a recommendation by a primary
care or consulting physician (6 [40.0%] of 15 patients).
Conclusion. ED providers hospitalize many low-risk patients with CAP, most frequently for a comorbid illness.
Although higher-risk patients are infrequently treated as outpatients, this decision is often based on the request
of an involved physician.
Community-acquired pneumonia (CAP) causes 4 mil-
lion episodes of illness and results in more than 1 mil-
lion hospital admissions in the United states each year
[1]. Evidence suggests that physicians tend to overes-
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timate the risk of death among patients with CAP, and
these overestimates are associated with the decision to
hospitalize patients at low risk [2]. Hospital admission
of low-risk patients with CAP is far more costly and
often less desirable for such patients [3, 4].
The pneumonia severity index (PSI) is a clinical pre-
diction rule for prognosis designed to help physicians
objectively determine the initial site of treatment for
patients with this illness [5]. Several randomized trials
and nonrandomized prospective studies have demon-
strated the effectiveness and safety of using the PSI to
reduce the proportion of low-risk patients hospitalized
from the emergency department (ED) [6–10], and to
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ensure that higher risk patients are not inappropriately dis-
charged to the outpatient setting [9].
Despite guideline recommendations to treat low-risk patients
with CAP (those in PSI risk classes I–III) as outpatients and
to hospitalize higher-risk patients, medical providers in the ED
hospitalize 38%–62% of low-risk patients [6, 7, 9–11] and dis-
charge 3%–13% of higher risk patients to the outpatient setting
[7, 9, 10]. It has been argued that, when used to determine the
initial site of treatment, the PSI may not address certain patient
psychosocial (eg, homelessness, substance abuse, and/or in-
adequate home support) or medical conditions (eg, suspected
tuberculosis or endocarditis, exacerbations of chronic obstruc-
tive pulmonary disease or asthma, acute coronary syndrome,
acute heart failure, and/or inability to maintain oral intake)
that preclude outpatient treatment [12–14].
Most prior studies of the initial site of treatment for CAP
relied on medical record reviews to identify the patient and
system factors associated with the admission decision [12, 15–
18] and did not directly elucidate the reasons why physicians
treated low-risk patients as inpatients or higher-risk patients in
the outpatient setting. As part of the EDCAP trial to use the
PSI to determine the initial site of treatment of patients with
CAP [9], we asked all ED providers who made guideline-dis-
cordant decisions on site of treatment to explain the reasons
for nonadherence to guideline recommendations. The specific
aims of this project were to describe the reasons why medical
providers treated patients classified as (1) low risk by the PSI
as inpatients and (2) patients classified as higher risk by the
PSI as outpatients.
METHODS
Study design. This study was conducted as part of the EDCAP
trial, a 32-site cluster-randomized controlled clinical trial de-
signed to compare the effectiveness and safety of 3 guideline
implementation strategies of increasing intensity (low, mod-
erate, and high) to determine the initial site of treatment for
patients with CAP presenting to an ED [9]. Using a practice
guideline based on PSI risk stratification and arterial oxygen-
ation, ED providers identified patients at low risk and higher
risk of 30-day mortality. The practice guideline recommended
treatment at home for patients defined as low risk (ie, PSI risk
class of I, II, or III without arterial hypoxemia) and treatment
in the hospital for higher-risk patients (ie, PSI risk class of IV
or V and/or arterial hypoxemia).
The low-intensity strategy (used by 8 EDs) included the de-
velopment of a voluntary quality-improvement plan that ad-
dressed the initial site of treatment for low-risk patients, with
a practice guideline and supporting literature mailed to all med-
ical providers at these EDs. The moderate-intensity strategy
(used by 12 EDs) included all of the low-intensity strategies
plus the state-specific quality-improvement organizations (for
Pennsylvania and Connecticut) requesting each participat-
ing hospital to develop a plan addressing the initial site of treat-
ment for patients with pneumonia. At all moderate-intensity
sites, the research team also conducted a one-time, on-site ed-
ucational session to teach medical providers how to use the
PSI to determine the initial site of treatment. The high-intensity
strategy (used by 12 EDs) included all low-intensity and mod-
erate-intensity strategies, plus real-time provider reminders and
audit and feedback, combined with continuous quality-im-
provement activities to increase the proportion of low-risk pa-
tients treated as outpatients. For the present study, we focus
exclusively on patients managed at the 12 high-intensity EDs,
where we asked all providers who managed enrolled patients
to detail the reasons for nonadherence to guideline recom-
mendations. We decided to focus on high-intensity EDs, be-
cause physicians at these EDs were well informed of the guide-
line recommendations to treat low-risk patients in the outpa-
tient setting and higher-risk patients in the hospital. Thus,
guideline-discordant site-of-treatment decisions would most
likely be a consequence of disagreement with the guideline rec-
ommendations and not a simple lack of guideline awareness.
The EDCAP trial was approved by the institutional review
boards at all study sites, and we obtained informed consent
from all study participants. The methods, design, guideline im-
plementation strategies, and description of study outcomes are
described in detail elsewhere [9, 19].
Study population. Physicians from 12 EDs (6 in Connecti-
cut and 6 in Pennsylvania) recruited patients 24 hours a day, 7
days a week during the period from January through December
2001. Patient eligibility criteria were the detection of a new pul-
monary infiltrate on a chest radiograph and a clinical diagnosis
of pneumonia for a patient older than 18 years of age. We ex-
cluded patients with cases of hospital-acquired pneumonia, with
immunosuppression, and/or with specific comorbid conditions
(such as cystic fibrosis or pulmonary tuberculosis) that were
distinguishable from pneumonia, patients with a serology test
positive for human immunodeficiency virus, patients who were
pregnant, or patients with substance abuse problems or psycho-
social conditions incompatible with outpatient treatment, en-
rollment, or follow-up (eg, homelessness or incarceration). For
this analysis, we also excluded patients without a prospectively
calculated PSI risk class (ie, 19 patients), which precluded a de-
termination of the concordance of the actual site of treatment
with the guideline-recommended site of treatment, and patients
who were mistakenly classified as low-risk patients despite the
presence of arterial hypoxemia at the time of presentation (ie,
11 patients).
Data collection. Trained research nurses collected data on
the characteristics of participating EDs and surveyed all in-
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Table 1. Characteristics of Emergency Department (ED)
Medical Providers Who Treated Patients with Community-
Acquired Pneumonia (January–December 2001)
Characteristic
ED providers
( )np 109
Median age (IQR), years 43.0 (38.2–48.0)
Male 80.7
Racea
White, not Hispanic 84.3
Black, not Hispanic 2.8
Hispanic 0.0
Asian or Pacific Islander 9.3
Other 3.7
Years since medical school graduation
!10 years 33.9
10–20 years 42.2
120 years 23.9
Practice specialty
Emergency physician, director 8.3
Emergency physician 78.0
Other specialtyb 12.8
Nurse practitioner or physician assistant 0.9
No. of ED shifts per month
1–4 16.4
5–11 20.9
112 62.7
NOTE. Data are percentage of patients, unless otherwise indicated.
The 12 participating EDs had a median volume of 25,899 patients per
year (range, (17,619–58,000 patients per year), and 6 EDs were in teach-
ing hospitals. IQR, interquartile range.
a Information on race was missing for 1 ED provider. The calculation
of percentages for this variable was based on 108 ED providers.
b Other provider specialties were internal medicine and family
practice.
volved ED medical providers to determine their demographic
and professional characteristics. They also performed medical
record reviews, to collect data on the demographic character-
istics, comorbid conditions, vital sign and physical examination
findings, and pertinent laboratory and radiographic findings
from presentation of each enrolled patient. ED providers pro-
spectively documented all of the demographic and clinical data
(eg, medical history, results of physical examinations, and lab-
oratory and radiographic findings) that comprise the PSI on a
form with instructions for the calculation of a risk score, as-
signment to a PSI risk class, and a recommendation for the
site of treatment based on the PSI risk class and level of arterial
oxygenation. This form also included a disclaimer that the ul-
timate decision should be consistent with the provider’s clinical
judgment. We classified patients as low risk or higher risk on
the basis of data recorded by the ED provider at the time of
the initial site-of-treatment decision. Low-risk patients were
defined as patients in the PSI risk class of I, II, or III without
arterial hypoxemia, and higher-risk patients were defined as
patients in PSI risk class of IV or V with or without arterial
hypoxemia (defined as a PaO2 !60 mm Hg or an oxygen sat-
uration !90%).
Research nurses administered patient-specific surveys (with-
in 1 week of patient enrollment) to all ED medical providers
who made an initial site-of-treatment decision that was discor-
dant with the guideline recommendations, to elicit the reasons
why the providers deviated from these recommendations. The
survey included a set of a priori categories delineating reasons
for not adhering to the guideline recommendations. ED providers
also had the opportunity to add open-ended responses. A panel
of 3 investigators reviewed each of these open-ended responses
and used majority consensus to assign them to a unique category.
The panel established 8 final, consensus-based categories ex-
plaining why low-risk patients were hospitalized and 6 categories
explaining why higher-risk patients were treated as outpatients.
Analyses. We compared baseline characteristics of low-risk
patients who received outpatient or inpatient care and higher-
risk patients who received outpatient or inpatient care. We used
the x2 test or the Fisher exact test to compare categorical var-
iables and the nonparametric Wilcoxon rank-sum test to com-
pare continuous variables. We used 2-sided P values of !.05 to
define statistical significance. We expressed as proportions the
reasons for the providers’ guideline-discordant site-of-treat-
ment decisions.
RESULTS
Characteristics of study sites and medical providers. The 12
participating EDs had a median volume of 25,899 patients per
year, and 6 EDs were in teaching hospitals (Table 1). We sur-
veyed 109 (70.8%) of 154 ED providers who enrolled study
patients at these sites and who made 1 site-of-treatment de-
cisions discordant with guideline recommendations. Most of
the providers were male (88 [80.7%] of 109 providers) and
identified themselves as ED physicians (94 [86.2%] of 109 pro-
viders) and as white (91 of 108 providers [84.3%]).
Study population. Providers enrolled 1336 (75.1%) of the
1779 eligible patients who were diagnosed with CAP at the 12
participating high-intensity EDs. After excluding 19 patients
without a prospectively calculated PSI and 11 patients who were
mistakenly classified as low-risk despite arterial hypoxemia,
1306 patients were in the final study population (Figure 1).
Overall, providers made 278 site-of-treatment decisions that
were discordant with guideline recommendations, hospitalizing
258 (37.4%) of 689 low-risk patients and discharging 20 (3.2%)
of 617 higher-risk patients. Providers completed surveys with
regard to the reasons why they made guideline-discordant de-
cisions for 249 (96.5%) of 258 low-risk inpatients and 15
(75.0%) of 20 higher-risk outpatients.
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Figure 1. Identification of the final study sample. PSI, pneumonia severity index.
Compared with the 431 low-risk patients treated as outpa-
tients, the 258 low-risk patients treated as inpatients were old-
er, and a higher percentage were insured with a fee-for-service
healthcare plan and were nursing home residents (Table 2). The
low-risk inpatients were also more likely to have congestive
heart failure, cerebrovascular disease, renal disease, and ab-
normal vitals signs (tachycardia, fever or hypothermia, and
tachypnea) and pleural effusion detected by radiography. Be-
cause of these characteristics, low-risk inpatients were more
likely than low-risk outpatients to be classified in the PSI risk
class of II or III. Compared with the 597 higher-risk patients
who were treated as inpatients, the 20 higher-risk outpatients
were less likely to have heart failure and more likely to be
classified in the PSI risk class of I, II, or III, with a low level
of arterial oxygenation as the sole determinant of a high-risk
designation.
Reasons why ED medical providers made discordant site-
of-treatment decisions. For the 249 low-risk patients who
were hospitalized and whose reasons for admission were doc-
umented, ED providers indicated 1 reason for 130 patients
(52.2%), 2 reasons for 81 patients (32.5%), and 3 reasons
for 37 patients (15.7%). ED providers cited concomitant co-
morbid illnesses precluding outpatient treatment for 178 pa-
tients (71.5%); the illnesses most frequently identified were
pulmonary (36 patients), cardiac (34 patients), and neurolog-
ical diseases (31 patients) (Table 3). In addition, they reported
that 73 (29.3%) patients had vital signs, symptoms, oxygen
saturation levels, or laboratory values that they believed were
incompatible with outpatient care. For 48 (19.3%) patients, the
patient’s primary care physician or a consultant specifically
requested hospitalization.
Medical providers completed the survey for 15 (75.0%) of
20 higher-risk outpatients. These 15 patients were most often
treated as outpatients because of the request of the primary
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Table 2. Comparison of Baseline Characteristics of Low-Risk Patients and Those of Higher-Risk Patients, by Severity of
Illness and Initial Site of Treatment
Characteristic
Low-risk patientsa Higher-risk patientsb
Outpatient
( )np 431
Inpatient
( )np 258
All
( )np 689 P
Outpatient
( )np 20
Inpatient
( )np 597
All
( )np 617 P
Median age (IQR), years 45 (34–60) 65.5 (51–75) 53 (37–69) !.001 76 (48–89.5) 78 (72–84) 78 (71–84) .42
Female sex 55.5 57.0 56.0 .70 50.0 48.4 48.5 .89
White, not Hispanic 76.0 81.4 78.1 .11 95.0 89.8 89.9 .79
Health insurance status
Health maintenance organization 29.7 32.8 30.9 .007 15.0 22.4 22.1 .53
Fee for service 53.6 59.0 55.6 80.0 75.4 75.5
Uninsured or unknown 16.7 8.2 13.5 5.0 2.2 2.3
Nursing home resident 0.5 2.7 1.3 .031 15.0 13.4 13.4 .74
Comorbid illnesses
Congestive heart failure 1.4 10.9 4.9 !.001 10.0 30.7 30.0 .047
Cerebrovascular disease 1.6 5.0 2.9 .010 5.0 14.2 13.9 .34
Renal disease 0.5 3.9 1.7 .001 20.0 12.6 12.8 .31
Neoplastic disease 0.7 0.8 0.7 1.99 10.0 9.2 9.2 .71
Liver disease 0.2 0.4 0.3 1.99 5.0 1.2 1.3 .23
Physical examination findings
Pulse rate 1125 beats/min 4.4 11.6 7.1 !.001 0.0 15.9 15.4 .06
Temperature !35C or 40C 2.8 6.2 4.1 .028 0.0 10.2 9.9 .25
Respiratory rate 130 breaths/min 0.7 5.0 2.3 !.001 5.0 24.3 23.7 .06
Systolic blood pressure !90 mm Hg 0.7 1.9 1.2 .16 0.0 5.2 5.0 .62
Altered mental status 0.5 0.8 0.6 .63 5.0 17.8 17.3 .23
Laboratory and radiographic results
Detection of pleural effusion
radiography 1.4 4.3 2.5 .019 10.0 9.5 9.6 1.99
Glucose level 250 mg/dL 1.4 3.5 2.2 .07 0.0 5.4 5.2 .62
BUN level 30 mg/dL 0.7 1.6 1.0 .43 20.0 22.4 22.4 1.99
PaO2 !60 mm Hg or O2
saturation !90% … … … … 45.0 54.8 54.5 .39
Hematocrit !30% 0.2 1.7 1.6 .07 0.0 6.5 6.3 .63
Sodium level !130 mmol/L 0.0 0.0 0.0 … 5.0 6.0 6.0 1.99
Arterial pH !7.35 0.0 0.0 0.0 … 0.0 4.4 4.2 1.99
PSI risk class
Class I, no hypoxemia 55.5 14.7 40.2 !.001
Class II, no hypoxemia 32.7 43.0 36.6
Class III, no hypoxemia 11.8 42.2 23.2
Classes I–III, with hypoxemia 45.0 18.6 19.4 .025
Class IV 40.0 63.8 63.0
Class V 15.0 17.6 17.5
NOTE. Data are percentage of patients, unless otherwise indicated. IQR, interquartile range; PSI, pneumonia severity index.
a Low-risk patients were defined as those in risk class I, II, or III who did not have arterial oxygen desaturation at presentation.
b Higher-risk patients were defined as those in risk class IV or V, or with arterial oxygen desaturation at presentation.
care physician or a consultant (6 patients [40.0%]), because of
rapid improvement in the patient’s condition or a change in
the diagnosis in the ED (5 patients [33.3%]), or because of
discharge from the ED back to a nursing home (3 patients
[20.0%]) (Table 4).
DISCUSSION
As part of the EDCAP trial designed to assess the effectiveness
and safety of implementing a PSI-based practice guideline, we
found that 37% of low-risk patients were hospitalized and 3%
of higher-risk patients were treated as outpatients, even with-
in the 12 EDs that received the most intensive strategies to
implement the guideline recommendations. The ED medical
providers responsible for hospitalizing low-risk patients most
frequently attributed their decisions to the presence of con-
comitant medical illnesses or abnormal vital signs, symptoms,
or laboratory values precluding outpatient care. Other fre-
quently identified reasons for overriding the guideline rec-
ommendation to manage low-risk patients in the outpatient
setting included the following: request for hospitalization made
by other treating physician, the patient, or the patient’s family;
provider’s perception that the case of pneumonia was more
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Table 3. Emergency Department Medical Provider Reasons for Treating Low-Risk
Patients in the Hospital
Reason for hospitalization
No. (%) of low-risk
patients
( )np 249
Comorbid illnesses precluding outpatient treatment 178 (71.5)
Pulmonary diseasesa 36 (14.5)
Cardiac diseasesb 34 (13.7)
Neurologic diseasesc 31 (12.4)
Infectious diseases or complicationsd 8 (3.2)
Diabetes mellitus 3 (1.2)
Renal failure 3 (1.2)
Miscellaneous medical problems 19 (7.6)
Abnormal symptoms, vital signs, or laboratory findings 73 (29.3)
Abnormal symptoms or vital signse 48 (19.3)
Arterial oxygen desaturationf 22 (8.8)
Abnormal laboratory findingsg 13 (5.2)
Primary care physician or consultant requested hospitalization 48 (19.3)
Pneumonia more severe than indicated by PSI 30 (12.0)
Problems with outpatient therapyh 28 (11.2)
Patient or family requested hospitalization 24 (9.6)
Psychosocial issuesi 16 (6.4)
Required hospital servicesj 12 (4.8)
NOTE. The sum of percentages exceeds 100% because medical providers could indicate 11 reason
for each patient. PSI, pneumonia severity index.
a There were 16 patients with chronic obstructive pulmonary disease or asthma; 8 patients with
multilobar pneumonia detected by chest radiography; 8 patients with pleural effusion; 6 patients with
a pulmonary mass; and 1 patient with some other type of pulmonary disease.
b There were 15 patients with acute coronary syndrome; 11 patients with arrhythmia; 9 patients
with heart failure; and 3 patients with some other type of cardiac disease.
c There were 16 patients who were frail or had a serious neuromuscular disorder; 7 patients who
were in a stupor or coma, or had severe dementia or a psychiatric illness; 5 patients with syncope;
and 3 patients with some other type of neurologic disease.
d There were 2 patients with a suppurative infection and 6 patients with some other type of infectious
disease or complication.
e There were 23 patients with wheezing or dyspnea; 11 patients with fever; 6 patients who were
dehydrated; 4 patients with pleuritic chest pain; 6 patients with tachycardia; 4 patients with arterial
hypotension; and 4 patients with some other abnormal symptom or vital sign.
f Physician-reported PaO2 !60 mm Hg, oxygen saturation !90%, or other abnormality in arterial
oxygenation.
g There were 4 patients with an abnormal white blood cell count; 3 patients with hyperglycemia; 2
patients with hypokalemia; and 5 patients some other abnormal laboratory finding.
h Outpatient treatment previously failed, or patient was unable to take oral antibiotics or maintain
oral intake.
i Patient was either judged unreliable for outpatient treatment or required placement.
j For parenteral fluids, antibiotics, or blood transfusion; for pain control; or for pulmonary toilet or
cardiac monitoring.
severe than indicated by the PSI; and prior or anticipated fail-
ure of outpatient treatment.
Our results suggest that, for many providers, knowing that
a patient is at low risk of death based on PSI risk class may
not be enough to consider outpatient care if they have 1
prognostic marker associated with an increased risk of mortality
or adverse outcomes. A prior study found that certain medical
conditions such as cardiac (eg, arrhythmia or heart failure) and
neurological diseases (eg, Parkinson disease or multiple scle-
rosis) are common immediate and underlying causes of death
among patients with CAP [20]. Other comorbid diseases (eg,
coronary artery disease or asplenia), laboratory findings (eg,
leukopenia or elevated C-reactive protein), and radiographic
abnormalities (multilobar infiltrates) that are not included in
the PSI have been associated with an increased risk of death
among patients with CAP [21].
The presence of severe derangements in a physical sign or
laboratory value may also play a key role in a provider’s decision
to hospitalize a low-risk patient. The PSI was constructed with
dichotomous predictor variables (abnormal vs normal) to facil-
itate its use in clinical practice and may oversimplify the way
physicians interpret the predictor variables. For example, a phy-
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Table 4. Emergency Department (ED) Medical Provider Reasons for Treating Higher-Risk Patients in the Out-
patient Setting
Reason for outpatient treatment
No. (%) of
higher-risk patients
( )np 15
Primary care physician or consultant requested dischargea 6 (40.0)
Patient improved, diagnosis changed in ED, or pneumonia less severe than indicated by PSIb 5 (33.3)
Discharged to nursing home from ED 3 (20.0)
Physician judged patient “not sick enough” to admitc 2 (13.3)
Patient or family refused hospitalization or requested discharged 2 (13.3)
Physician disagreed with guideline recommendation to admite 2 (13.3)
NOTE. The sum of percentages exceeds 100% because providers could indicate 11 reason for each patient. PSI, pneumonia
severity index.
a There was 1 patient from a nursing home; 1 patient with good home support; and 1 patient who was discharged for some other
reason.
b There were 2 patients whose oxygen desaturation improved with treatment; 2 patients whose diagnosis changed; and 1 patients
whose pneumonia was less severe than indicated by the PSI.
c There was 1 patient who rapidly improved and 1 patient whose physician refused admission because the patient had no insurance.
d There was 1 patient who had no insurance and refused admission, and 1 patient who had good home support.
e Both patients were from a nursing home.
sician would be unlikely to discharge a previously healthy 20-
year-old patient with severe systolic hypotension, despite the ab-
sence of other prognostic variables and a risk class II designation
based on the PSI. Moreover, patients designated as low risk on
the basis of the PSI may have important medical and psychosocial
contraindications to outpatient care. For example, administering
oral antibiotics to patients with intractable vomiting in an out-
patient setting is not an option. Likewise, patients who use in-
travenous drugs, abuse alcohol, or have severe psychiatric con-
ditions or severely impaired cognitive dysfunction may require
hospitalization to ensure compliance with treatment, regardless
of the severity of illness. Finally, patients with rare comorbid
conditions (eg, neuromuscular disease) who were systematically
excluded from studies validating the PSI may also require hos-
pitalization. In such circumstances, the PSI should not super-
sede a physician’s judgment [5]. Our findings confirm that phy-
sicians apply their clinical judgment to appropriately override
the guideline site-of-treatment recommendations.
In our study, only 3.2% of higher-risk patients were dis-
charged against guideline recommendation, mostly for the fol-
lowing reasons: the patient’s family physician or a consultant
requested discharge, the patient’s initial hypoxemia rapidly im-
proved or the admission diagnosis changed, or the patient was
discharged to a nursing home. In a prior study, the most com-
mon explanation for discharge of higher-risk patients from the
ED was patient or family preference, despite the physician’s rec-
ommendation for admission [7]. Although the EDCAP study
was not designed to examine clinically meaningful differences in
mortality across the 3 study arms for higher-risk patients, this
study demonstrated that, for higher-risk patients, mortality was
nearly identical across the 3 study arms, despite a frequency of
outpatient treatment that ranged 3-fold from 2.4% to 9.6% [9].
Few prior studies directly asked ED physicians why they
treated individual low-risk patients with CAP in the hospital
[2, 22]. Our findings are consistent with the results of a prior
study that directly surveyed 47 ED physicians to determine the
reasons for admitting patients despite guideline recommen-
dations for outpatient care [22]. In this survey, the most fre-
quent reasons given for nonadherence to guideline recom-
mendations were coexisting medical problems, preference for
admission by the primary physician, physician belief that the
pneumonia severity was more acute than indicated by the PSI,
patient or family preferences for admission, lack of adequate
home or social support, and failure of outpatient therapy [22].
An earlier study that asked 292 medical practitioners to describe
the patient characteristics that influence the admission of low-
risk patients found, in general, that coexisting medical illnesses,
a “very sick” clinical appearance, detection of multilobar lung
involvement on chest radiograph, arterial hypoxemia, and lack
of patient reliability were strongly associated with hospitali-
zation [2].
Several prior studies used chart reviews rather than direct
physician surveys to identify patient and/or site characteristics
associated with the admission of low-risk patients with CAP [12,
15–18, 23, 24]. In these studies, the factors found to be associated
with hospital admission of low-risk patients included comorbid
conditions that are not contained in the PSI (cognitive impair-
ment, history of coronary disease, diabetes mellitus, or pulmo-
nary disease), large or complicated pleural effusions, lack of re-
sponse to previous antibiotic therapy, detection of multilobar
pneumonia on chest radiograph, infection with a high-risk path-
ogen, noncompliance with or failure to respond to previous out-
patient therapy, home therapy with oxygen or corticosteroids,
and a variety of psychosocial characteristics (eg, living home
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alone, homelessness, or substance abuse) [12, 15–18, 23, 24]. A
study of 845 low-risk patients with CAP who were treated as
inpatients found that 79.9% of patients had1 contraindication
to outpatient treatment or 1 significant comorbid condition
or treatment that precluded outpatient care [18]. The remaining
20.1% of patients may have been treated as inpatients at the
discretion of the managing medical provider because of patient
or family preferences, the provider’s aversion to risk, or the pro-
vider’s judgment that the patient’s severity of illness warranted
hospitalization despite their low-risk classification and the ab-
sence of medical or psychosocial contraindications to outpa-
tient care [18].
The goal of our study was to elucidate the reasons why ED
providers made guideline-discordant site-of-treatment decisions
and not to compare the medical outcomes of patients managed
concordant versus discordant with guideline recommendations.
Nevertheless, a prior study using data from 1493 low-risk patients
without a contraindication to outpatient care from the EDCAP
trial found a higher unadjusted 30-day mortality among low-
risk inpatients than among low-risk outpatients (2.6% vs 0.1%;
), but this mortality difference disappeared after adjustingP ! .01
the propensity score for the site of treatment [25]. In this ob-
servational study, although satisfaction with the site of treatment
was not different between low-risk outpatients and low-risk in-
patients, the low-risk outpatients were more likely than the low-
risk inpatients to return to work or usual activities [25]. Another
study that randomized 224 patients with CAP (PSI risk class II
or III) to receive outpatient or inpatient treatment did not find
any differences in overall mortality or in outcome measures oth-
er than mortality [8].
Our study has several limitations. First, this study was per-
formed within the randomized, controlled EDCAP trial to com-
pare 3 different guideline implementation strategies for CAP.
This trial excluded patients who were considered to have hos-
pital-acquired pneumonia, immunosuppression, specific co-
morbid conditions (such as cystic fibrosis and tuberculosis), or
psychosocial conditions (eg, homelessness) or substance abuse
problems that were incompatible with outpatient care. There-
fore, this study could not identify these conditions as potential
reasons to override guideline recommendations. Second, be-
cause providers were surveyed up to 1 week after patient en-
rollment, recall bias could have affected the accuracy of our
data. Furthermore, we did not objectively verify the extent to
which the reported reason for overriding the guideline rec-
ommendations was truly present. Finally, the small number of
higher-risk patients for whom ED providers made guideline-
discordant site-of-treatment decisions may have diminished
our ability to fully determine the reasons why providers decid-
ed to manage higher-risk patients as outpatients.
In summary, despite intense efforts to implement a PSI-based
guideline to identify low-risk patients with CAP for outpatient
treatment, ED providers used their clinical judgment to hos-
pitalize nearly 40% of such patients. In most cases, providers
reported that concomitant comorbid illnesses warranted hos-
pitalization of low-risk patients. In contrast, higher-risk patients
with CAP were infrequently treated in the outpatient setting,
most often because of requests by comanaging physicians. Al-
though ED providers reported that, in most instances, they
overrode guideline recommendations because of specific clin-
ical factors, many guideline-discordant decisions were based on
patient, family, or physician requests, or because physicians
subjectively judged the case of CAP to be more or less severe
than suggested by the PSI. Additional educational efforts and/
or alternative guideline implementation strategies may be able
to further safely reduce the proportion of guideline-discordant
site-of-treatment decisions for patients with CAP.
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